Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 13, Issue 1 pp 411—423
The improved anticancer effects of Bortezomib-loaded hollow mesoporous silica nanospheres on lymphoma development
Figure 3. BTZ@HMSNs augments cell death of lymphoma. (A) Live/dead staining detection for SNK-1 cells treated with PBS (control), HMSNs, BTZ (75 nM), BTZ@HMSNs (containing 75 nM of BTZ). Scale bar equals 5 nm. (B) Cell apoptosis rate of SNK-1 cells treated with PBS (control), HMSNs, BTZ, BTZ@HMSNs by flow cytometry analysis. (C) The expression of apoptosis-related proteins (Bcl-2, Bax, and cleaved-caspase-3) in SNK-1 cells treated with PBS (control), HMSNs, BTZ, BTZ@HMSNs by western blotting. BTZ, bortezomib; HMSNs, hollow mesoporous silica nanospheres. The differences between groups were analyzed by one-way ANOVA followed by multiple comparison with Tukey test. *P < 0.05 and **P < 0.01. Values are means ± SD.